Clinical Trials Logo

Paraplegia clinical trials

View clinical trials related to Paraplegia.

Filter by:

NCT ID: NCT04465825 Not yet recruiting - Clinical trials for Spinal Cord Injuries

Developing Strategies to Optimize the Exercise Response After Tetraplegia.

Start date: June 2021
Phase: N/A
Study type: Interventional

To identify means to improve exercise performance in participants with tetraplegia.

NCT ID: NCT04453943 Not yet recruiting - Clinical trials for Spinal Cord Injuries

Modeling, Optimization, and Control Methods for a Personalized Hybrid Walking Exoskeleton

Start date: July 1, 2020
Phase: N/A
Study type: Interventional

The central objective of this study is to validate new algorithms that coordinate between functional electrical stimulation (FES) and the exoskeleton during sitting-to-standing, walking, and standing-to-sitting movements. The secondary objective is to optimize the algorithms as well as assess their ability to reduce FES-induced muscle fatigue by using ultrasound imaging as a sensing modality. This study will include persons with no disabilities and persons with Spinal Cord Injury (SCI). A research set-up comprising of a lower-limb exoskeleton and FES system will be used to achieve sitting-to-standing, walking, and standing-to-sitting movements. Ultrasound Imaging probes may be used to record muscle activity of the stimulated muscles. The signals derived from ultrasound will be used to optimize FES in order to reduce muscle fatigue as well as assess muscle fatigue.

NCT ID: NCT04397250 Recruiting - Paraplegia Clinical Trials

High-intensity Interval Training for Cardiometabolic Health in Persons With Spinal Cord Injury

Start date: October 1, 2020
Phase: N/A
Study type: Interventional

Persons with chronic paraplegia at an increased risk of developing cardiovascular disease and type-2 diabetes compared to the able-bodied population. There is mounting evidence from the able-bodied literature that high-intensity interval training (HIIT) is an effective way to improve cardiometabolic health outcomes, but this effect has yet to be investigated in persons with chronic paraplegia. This study is recruiting adults (aged 18-65 years) with paraplegia (T2 or below) who sustained their spinal cord injury more than one-year ago. Participants will need to attend the laboratory at the University of Bath on two occasions (baseline and follow-up testing) separated by eight weeks. Following the first visit, participants will be randomised to a exercise group or control group. For those in the exercise group, participants will be provided with an arm crank ergometer for use in their home, and be asked to perform four exercise sessions per week (30 min each) for six weeks. For those in the control group, participants will be asked to continue their normal lifestyle.

NCT ID: NCT04378218 Completed - Paraplegia, Spinal Clinical Trials

Cardiovascular Effects of High Intensity Interval Training in Individuals With Paraplegia

HIIT
Start date: December 12, 2019
Phase: N/A
Study type: Interventional

The study seeks to determine whether high intensity interval training has an effect on cardiovascular parameters in wheelchair users with paraplegia.

NCT ID: NCT04266808 Not yet recruiting - Clinical trials for Spinal Cord Injuries

Interactive Telehealth for Wheelchair Users

Start date: March 2020
Phase: N/A
Study type: Interventional

During typical daily activity, people with established spinal cord injury perform significantly fewer pressure-relief maneuvers than the recommended frequency while overestimating their adherence on recall surveys of pressure relief activity. The rate of pressure ulcer recurrence in individuals with a prior ulcer is 44% in those with surgical repair and as high as 75% in those with non-surgical healing indicating that increased attention to pressure relief is critical for these individuals.This study will evaluate the efficacy of a wheelchair sensor and app-based biofeedback for establishing healthy self-management behaviors (pressure relief maneuvers and daily physical activity). Investigators will enroll 50 participants with paraplegia from spinal cord injury who use a manual wheelchair for mobility and have a history of pressure ulcer that has healed or is six months post-surgical repair. Participants will be randomized into one of two groups: an intervention group that will receive an education intervention and the proposed technology to be used for one year, and a control group that will receive only the education intervention. The primary outcome will be pressure ulcer occurrence over one year. Investigators hypothesize that participants receiving the intervention of biofeedback on their pressure relief activity will have a lower recurrence of pressure ulcer than the education only control group. Secondary outcomes include depressive symptoms, self-efficacy, participation and satisfaction with life. Investigators hypothesize that increasing physical activity will reduce depressive symptoms and improve participation and satisfaction with life.

NCT ID: NCT04215939 Completed - Clinical trials for Spinal Cord Injuries

Assessment of Vasomotion of People With Spinal Cord Injury

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

Spinal cord injury (SCI), causes loss of supra-spinal control of the sympathetic nervous system and in some cases loss of sensation. As a result, people with SCI have impaired thermoregulatory system and the consequence of this thermoregulatory dysfunction, is that they cannot respond to the environmental changes. All the above lead to dysregulation in vasomotor tone, skeletal muscle shivering and sweating dysfunction. It is well known that skin plays an important role in regulating body temperature and regulates interactions between the environment and human body. A previous study in people with incomplete SCI showed that there are no differences in core temperature between patients with different level of mobility and sensation and different level of lesion, but there are significant differences in skin temperature. As mentioned above people with SCI have an impaired thermoregulatory capacity due to sudomotor and vasomotor dysfunction and that leads to greater thermal strain during rest and exercise when they expose to hot conditions. A previous study that performed exercise in people with SCI, highlights the fact that because of the impaired evaporative heat loss during exercise in hot conditions, they are in great risk. Because of this risk they propose different cooling strategies that promote evaporation such as fans and water spraying. It is therefore important to observe the thermoregulatory function (vasomotion and sudomotor) in people with SCI when they are exposed to different environments (cold, neutral and warm).

NCT ID: NCT04215081 Completed - Clinical trials for Spinal Cord Injuries

ExoAtlet II For SCI Patients

EXOATLET2SCI
Start date: November 18, 2019
Phase: N/A
Study type: Interventional

This study will evaluate the ExoAtlet II exoskeleton for safety and effectiveness of providing persons with a spinal cord injury (SCI) who are non-ambulatory or have limited ambulatory function, to stand up and ambulate under a variety of conditions.

NCT ID: NCT04180098 Completed - Clinical trials for Hereditary Spastic Paraplegia

Improving Gait Adaptability in Hereditary Spastic Paraplegia

Move-HSP
Start date: December 1, 2019
Phase: N/A
Study type: Interventional

This study evaluates the effects of ten hours C-mill training on gait adaptability in participants with hereditary spastic paraplegia (HSP). Half of the participants start with five weeks of C-mill training (ten 1-hour sessions). The other participants are placed on a waiting list, which is followed by the same five weeks of C-mill training (ten 1-hour sessions). It is hypothesized that ten hours of context specific C-mill training is effective in improving gait adaptability in participants with pure HSP.

NCT ID: NCT04110561 Completed - Clinical trials for Spinal Cord Injuries

Evaluation of Safety and Performance of the Atalante System With Patients With Lower Limb Paralysis

Start date: May 5, 2018
Phase: N/A
Study type: Interventional

The study is a prospective, open, bicentric and observational study. It is conducted to assess the safety and performance of the Atalante exoskeleton system with patients with lower limb paralysis. The principal objective is to assess the performance of the Atalante system in performing ambulatory functions with motor complete SCI patients characterized by the success rate in performing a 10mWT at the last session of training with the Atalante system.

NCT ID: NCT04101643 Recruiting - Clinical trials for Hereditary Spastic Paraplegia Type 5

PCSK9 Inhibitor Treatment for Patients With SPG5

Start date: September 29, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Spastic paraplegia type 5 (SPG5) is a rare subtype of hereditary spastic paraplegia, a highly heterogeneous group of neurodegenerative disorders defined by progressive neurodegeneration of the corticospinal tract motor neurons. SPG5 is caused by recessive mutations in the gene CYP7B1 encoding oxysterol-7a-hydroxylase. This enzyme is involved in the degradation of cholesterol into primary bile acids. CYP7B1 deficiency has been shown to lead to accumulation of neurotoxic oxysterols. Oxysterols were found to impair metabolic activity and viability of human cortical neurons at concentrations found in SPG5 patients, indicating that elevated levels of oxysterols might be key pathogenic factors in SPG5. Monoclonal antibodies that inhibit proprotein convertase subtilisin-kexin type 9 (PCSK9) have emerged as a new class of drugs that effectively lower cholesterol levels. Evolocumab, a member of this class, is a fully human monoclonal antibody that reduces LDL cholesterol levels by approximately 60%. We thus performed this interventional trial with Evolocumab 420 mg for SPG5 patients.